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1. Introduction 
The importance of protein-metal ion interactions 
for biological activity and physiology of proteins is 
apparent in the examle of insulin, which is stored in 
the pancreatic p-cells in microcrystals with high con- 
tent of Zn*+ [ 1,2]. It is also known that Ca’+ and 
MgZC have an important role in the mechanism of 
secretion and action of insulin [2,3]. In vitro studies 
have shown that presence of Zn*+ and other metals 
(e.g., Cd*‘, Co”) facilitates the formation of insulin 
crystals [4,5] and aggregates [6,7]. The hypothesis 
about coordination of Zn2+ to insulin through histidine 
residues has been confirmed by crystallographic 
studies [8]. 
The influence of Zn” on the electronic spectra of 
insulin has been studied [9] in acid media. This 
question has been touched recently in [ 10,l l] This 
paper deals with the interaction of divalent metal 
cations with insulin in neutral and mildly alkaline 
solutions, i.e., under pH values near to the physio- 
logical. 
Interaction of the insulin with Zn’+, Cd*+, Co*+, 
Ca*+ and Mg*’ has been studied by ultraviolet differ- 
ence spectroscopy. In the neutral media, the presence 
of Zn*+, Cd*+ and Co’+ causes the red shift of tyrosyl 
bands in the insulin spectrum. Interaction of insulin 
with Ca*+ and Mg*’ at pH 7-8 as well as with all 
metals in acid medium did not lead to spectral changes. 
The plausible interpretation consists in the confor- 
mational changes of insulin aggregates probably near 
the tyrosines of insulin A chain. 
This work has been presented jn part at the 8th Meet. 
Czechoslovak. Biochem. Sot. Spindlerfiv Mlqn, 26th Oct. 1978 
374 
2. Materials and methods 
Insulin (beef) was supplied by Sigma, London (lot 
no. 24 C 3 130,24.1 units/mg). Zn2+ content (0.3%) 
was determined by atomic absorption spectroscopy 
(Varian 1200, Melbourne); water content was checked 
to be 10.5%. 
Preparation of stock solution of Zn*+-free insulin: 
a solution of insulin (4 g/l) in 0.0 1 M HCl was dialysed 
36 h against 1 .O mM HCl to remove Zn2+ [ 121, then 
shortly against 0.01 M NaOH to obtain alkaline pH. 
Ionic strength was adjusted by dialysis against 0.1 M 
NaCl overnight. For each measurement, stock solu- 
tion was diluted by 0.1 M NaCl to 1.6 X 10W4 M and 
finally pH was adjusted. 
Difference spectra were made in a two-cell arrange- 
ment: one cell contained insulin solution with pertur- 
bant (metal chloride); the second cell contained 
insulin solution alone. To assure the same insulin 
concentration in both cuvettes, a solution of metal 
chloride was placed into the cell, dried, then insulin 
solution added. Spectra were recorded on the Specord 
UV VIS (Carl Zeiss, Jena) spectrophotometer with 
the EZ 2 (Labora, Prague) external recorder, 1 cm- 
quartz cuvettes were used in a thermostated holder 
(25’C). Insulin concentration was checked spectro- 
photometrically (Earn = 6 100) [ 131. 
3. Results and discussion 
Interaction of insulin with Zn’+ at pH 6.8-8.0 
resulted in the difference spectrum (fig.1) which 
corresponds to the red shift of the tyrosine absorp- 
tion bands. In the spectra, no significant perturba- 
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Fig.1. Insulin difference spectrum. Znzf, 1.6 X 10m4 M; 
Zn’+-free insulin, 1.6 X 10m4 M; pH 7.45. 
tion of phenylalanine chromophores (250~-270 nm) 
was present. Figure 2A shows the dependence of the 
perturbation magnitude (expressed as AE’ = Ae2s8 - 
AESOP) on the insulin : Zn2+ molar ratio, fig.2B depen- 
dence on the pH at 6.8-8.0. In the acid medium 
(pH 2-3) no difference spectra were observed. It can 
be easily explained by the coordination of Zn2+ 
through histidine residues, which are protonized in 
acid media. The absence of the insulin spectrum 
perturbation [9] is thus consistent with this inter- 
pretation. 
The nature of the interaction of both transition 
metals (Cd2’, Co”) with insulin is similar. Observed 
difference spectra are nearly the same in shape but 
greater in magnitude (fig.2A). On the other hand, 
both Ca2’ and Mg” do not perturb the insulin spec- 
trum either in neutral or in acid medium. This fact 
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Fig.2. (A) Dependence of the perturbation magnitude Ae’ * A similar conclusion about the interaction of Zn” with 
(defined as AezK8 - AezTr) on the no. metal atoms/insulin insulin was reached independently by CD study of Arquilla 
hexamer n. Full circles, Cd’+; full squares, Zn2+; pH 7.45. et al. (1978) Biochem. J. 175, 289-297; whose work was 
(B) Dependence of Ae’ on the pH (Zn’+; 2.4 X lo-“ M). brought to our attention after this manuscript had been 
Insulin, 1.6 X lo-’ M. prepared 
may be ascribed to the different ability of transition 
and alkaline earth metals to complex with nitrogen 
bases [ 141. In the light of absence of the insulin con- 
formational changes due to Ca2’/Mg2’-insulin inter- 
action, it seems that the regulatory mechanisms [2,3] 
involving Ca2+ and/or Mg” cannot include the direct 
metal-insulin interaction. 
The appearence of the difference spectra in the 
case of neutral and mildly alkaline media can be 
ascribed to: 
(1) Direct interaction of metal cations with tyrosine 
residues of insulin (parallel to this with histidine); 
(2) Conformational changes due to insulin aggrega- 
tion conditioned by presence of metal; 
(3) Conformational changes of existing aggregates 
caused by interaction with metal, and combina- 
tion of all these possibilities. 
To verify (l), a separate experiment with tyrosine 
and Zn2+ has been carried out. No perturbation of 
tyrosine chromophore spectra caused by interaction 
with Zn2+ has been observed. To discuss the involve- 
ment of insulin aggregation, one must consider that 
aggregations of monomers to dimers as well as of 
dimers to hexamers must involve conformational 
changes in the neighborhood of phenylalanine, namely 
the B 24 and B 2.5 for dimer and B 1 for hexamer 
formation [8,9]. However, such conformational 
changes have not been detected (see fig.l). Moreover, 
the perturbation of tyrosyls continues after the metal 
: insulin molar ratio when only hexamers are present 
[7]. Thus, the aggregation cannot be the principal 
cause of observed spectral changes. In the light of the 
reasons presented, the plausible interpretation is con- 
formational changes of the insulin aggregates presented 
in solution in the neighborhood of tyrosine residues*. 
Among 4 tyrosine residues (A 14, A 19, B 16, B 26) 
in the insulin molecule the tyrosines of A chain are 
still (after formation of hexamer) exposed [8,9,1 I]. 
Because the observed red shift of tyrosine bands 
corresponds to the lower accessibility of chromophore 
[ 151, changes of tyrosine exposure occur most 
probably in tyrosines of insulin A chain. 
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Although it is likely that the active insulin species 
is the insulin monomer [8], the importance of metal- 
insulin interaction follows from the fact that these 
monomers originate from the pancreatic microcrystals 
with Zn2+ high content. Thus, during the transport of 
secreted insulin from portal circulation to the target 
place a dissociation of zinc-insulin complex probably 
occurs which is accompanied with a conformational 
change. The differences in the insulin conformation 
in the presence and absence of zinc have been shown 
[ 161 to be reflected in the changed ability of insulin to 
react with antibodies and, moreover, in vitro and 
in vivo experiments have shown that the presence of 
Zn2+ strongly enhances the binding of insulin to liver 
plasma membranes. 
It can be concluded that the observed conforma- 
tional changes, which most probably involve the 
A-chain tyrosines at the surface of the insulin mole- 
cule, are a key event in the proposed [ 161 mechanism 
for fine modulation and control of insulin. 
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